Summary
This large-scale epigenome-wide association study, published in Nature in 2016, identified DNA methylation sites associated with body mass index across multiple international cohorts. The research examined whether these epigenetic markers could predict adverse health outcomes linked to adiposity, contributing to understanding of the molecular mechanisms underlying obesity and metabolic disease. The multi-cohort design and focus on epigenetic pathways as potential biomarkers may inform future stratification and prediction of obesity-related disease risk.
UK applicability
The findings identify epigenetic signatures potentially applicable to UK population health monitoring and obesity risk stratification, though the study was international and findings would require validation in UK-specific cohorts. The work may support development of methylation-based biomarkers for NHS-led obesity prevention and personalised health interventions.
Key measures
DNA methylation sites (CpG positions) associated with BMI; correlation with adiposity-related health outcomes; cross-cohort validation of epigenetic associations
Outcomes reported
The study identified DNA methylation sites associated with body mass index across multiple international cohorts and examined whether these epigenetic markers predict adverse health outcomes linked to adiposity. The research explored molecular mechanisms underlying obesity and metabolic disease risk through epigenetic biomarkers.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.